Deborah S Hasin1, Eliana Greenstein2, Christina Aivadyan2, Malki Stohl2, Efrat Aharonovich3, Tulshi Saha4, Rise Goldstein4, Edward V Nunes3, Jeesun Jung4, Haitao Zhang4, Bridget F Grant4. 1. Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA; New York State Psychiatric Institute, New York, NY 10032, USA. Electronic address: deborah.hasin@gmail.com. 2. New York State Psychiatric Institute, New York, NY 10032, USA. 3. Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA; New York State Psychiatric Institute, New York, NY 10032, USA. 4. Laboratory of Epidemiology and Biometry, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, USA.
Abstract
BACKGROUND: The purpose of this study was to assess the procedural validity of the substance disorder modules of the lay-administered Alcohol Use Disorder and Associated Disabilities Interview Schedule, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Version (AUDADIS-5) through clinician re-appraisal re-interviews. METHODS: The study employed a test-retest design among 712 respondents from the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). A clinician-administered, semi-structured interview, the Psychiatric Research Interview for Substance and Mental Disorders, DSM-5 version (PRISM-5) was used as the re-appraisal. Kappa coeffients indicated concordance of the AUDADIS-5 and PRISM-5 for DSM-5 substance use disorder diagnoses, while intraclass correlation coefficients (ICC) indicated concordance on dimensional scales indicating the DSM-5 criteria count for each disorder. RESULTS: With few exceptions, concordance of the AUDADIS-5 and the PRISM-5 for DSM-5 diagnoses of substance use disorders ranged from fair to good (κ=0.40-0.72). Concordance on dimensional scales was excellent (ICC≥0.75) for the majority of DSM-5 SUD diagnoses, and fair to good (ICC=0.43-0.72) for most of the rest. CONCLUSIONS: As indicated by concordance with a semi-structured clinician-administered re-appraisal, the procedural validity of the AUDADIS-5 DSM-5 substance use disorder diagnoses found in this study indicates that these AUDADIS-5 diagnoses are useful tools in epidemiologic studies. The considerably stronger concordance of the AUDADIS-5 and PRISM-5 dimensional DSM-5 SUD measures supports a current movement to place more emphasis on dimensional measures of psychopathology, and suggests that such measures may be more informative than binary diagnoses for research, and possibly for clinical purposes as well.
BACKGROUND: The purpose of this study was to assess the procedural validity of the substance disorder modules of the lay-administered Alcohol Use Disorder and Associated Disabilities Interview Schedule, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Version (AUDADIS-5) through clinician re-appraisal re-interviews. METHODS: The study employed a test-retest design among 712 respondents from the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). A clinician-administered, semi-structured interview, the Psychiatric Research Interview for Substance and Mental Disorders, DSM-5 version (PRISM-5) was used as the re-appraisal. Kappa coeffients indicated concordance of the AUDADIS-5 and PRISM-5 for DSM-5 substance use disorder diagnoses, while intraclass correlation coefficients (ICC) indicated concordance on dimensional scales indicating the DSM-5 criteria count for each disorder. RESULTS: With few exceptions, concordance of the AUDADIS-5 and the PRISM-5 for DSM-5 diagnoses of substance use disorders ranged from fair to good (κ=0.40-0.72). Concordance on dimensional scales was excellent (ICC≥0.75) for the majority of DSM-5 SUD diagnoses, and fair to good (ICC=0.43-0.72) for most of the rest. CONCLUSIONS: As indicated by concordance with a semi-structured clinician-administered re-appraisal, the procedural validity of the AUDADIS-5 DSM-5 substance use disorder diagnoses found in this study indicates that these AUDADIS-5 diagnoses are useful tools in epidemiologic studies. The considerably stronger concordance of the AUDADIS-5 and PRISM-5 dimensional DSM-5 SUD measures supports a current movement to place more emphasis on dimensional measures of psychopathology, and suggests that such measures may be more informative than binary diagnoses for research, and possibly for clinical purposes as well.
Keywords:
Alcohol Use Disorder and Associated Disabilities Interview Schedule-5; Alcohol use disorder; Psychiatric Research Interview for Substance and Mental Disorders-5; Reliability; Substance use disorder; Validity
Authors: L B Cottler; B F Grant; J Blaine; V Mavreas; C Pull; D Hasin; W M Compton; M Rubio-Stipec; D Mager Journal: Drug Alcohol Depend Date: 1997-09-25 Impact factor: 4.492
Authors: Robert E Drake; Carol L M Caton; Haiyi Xie; Eustace Hsu; Prakash Gorroochurn; Sharon Samet; Deborah S Hasin Journal: Am J Psychiatry Date: 2011-03-31 Impact factor: 18.112
Authors: Bridget F Grant; Deborah A Dawson; Frederick S Stinson; Patricia S Chou; Ward Kay; Roger Pickering Journal: Drug Alcohol Depend Date: 2003-07-20 Impact factor: 4.492
Authors: Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2015-09-02 Impact factor: 4.492
Authors: Sean Esteban McCabe; Tonda L Hughes; Brady T West; Rebecca J Evans-Polce; Phil T Veliz; Kara Dickinson; Vita V McCabe; Carol J Boyd Journal: J Clin Psychiatry Date: 2020-12-01 Impact factor: 4.384
Authors: Chiung M Chen; Young-Hee Yoon; Thomas C Harford; Bridget F Grant Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2017-04-11 Impact factor: 4.328
Authors: Walter Roberts; Kelly E Moore; Brian P Pittman; Mark T Fillmore; Sherry A McKee Journal: J Stud Alcohol Drugs Date: 2019-01 Impact factor: 2.582
Authors: Deborah S Hasin; Dvora Shmulewitz; Malka Stohl; Eliana Greenstein; Christina Aivadyan; Kara Morita; Tulshi Saha; Efrat Aharonovich; Jeesun Jung; Haitao Zhang; Edward V Nunes; Bridget F Grant Journal: Drug Alcohol Depend Date: 2015-04-06 Impact factor: 4.492
Authors: Simon B Goldberg; John C Fortney; Jessica A Chen; Bessie A Young; Keren Lehavot; Tracy L Simpson Journal: Adm Policy Ment Health Date: 2020-07